Green JB - Search Results

1

Cardiovascular Outcome Trial Update in Diabetes: New Evidence, Remaining Questions.

Herbst R, Bolton W, Shariff A, Green JB. Herbst R, et al. Among authors: green jb. Curr Diab Rep. 2017 Sep;17(9):67. doi: 10.1007/s11892-017-0898-8. Curr Diab Rep. 2017. PMID: 28726152 Review.

2

Are sulfonylureas passé?

Green JB, Feinglos MN. Green JB, et al. Curr Diab Rep. 2006 Nov;6(5):373-7. doi: 10.1007/s11892-006-0008-9. Curr Diab Rep. 2006. PMID: 17076998 Review.

3

Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Green JB, Feinglos MN. Green JB, et al. Curr Diab Rep. 2007 Oct;7(5):369-75. doi: 10.1007/s11892-007-0060-0. Curr Diab Rep. 2007. PMID: 18173970 Review.

4

New combination treatments in the management of diabetes: focus on sitagliptin-metformin.

Green J, Feinglos M. Green J, et al. Vasc Health Risk Manag. 2008;4(4):743-51. doi: 10.2147/vhrm.s3105. Vasc Health Risk Manag. 2008. PMID: 19065992 Free PMC article. Review.

5

Glycemic management in diabetes and the associated cardiovascular risk: are we helping or hurting our patients?

Koshizaka M, Green JB, Alexander JH. Koshizaka M, et al. Among authors: green jb. Circ J. 2012;76(7):1572-80. doi: 10.1253/circj.cj-12-0428. Epub 2012 Jun 16. Circ J. 2012. PMID: 22789974 Free article. Review.

6

The dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus: cardiovascular safety.

Green JB. Green JB. Postgrad Med. 2012 Jul;124(4):54-61. doi: 10.3810/pgm.2012.07.2566. Postgrad Med. 2012. PMID: 22913894 Review.

7

Determinants of successful glycemic control among participants in the BARI 2D trial: a post-hoc analysis.

Ismail-Beigi F, Lombardero MS, Escobedo J, Genuth S, Green J, Massaro E, Mooradian AD, Ovalle F, Whitehouse F, Zonszein J; BARI 2D Study Group. Ismail-Beigi F, et al. J Diabetes Complications. 2014 Jan-Feb;28(1):101-9. doi: 10.1016/j.jdiacomp.2013.01.006. Epub 2013 Mar 7. J Diabetes Complications. 2014. PMID: 23478173 Free PMC article.

8

Are current clinical trials in diabetes addressing important issues in diabetes care?

Lakey WC, Barnard K, Batch BC, Chiswell K, Tasneem A, Green JB. Lakey WC, et al. Among authors: green jb. Diabetologia. 2013 Jun;56(6):1226-35. doi: 10.1007/s00125-013-2890-4. Epub 2013 Apr 8. Diabetologia. 2013. PMID: 23564296 Review.

9

Depletion of circulating progenitor cells precedes overt diabetes: a substudy from the VA enhanced fitness trial.

Povsic TJ, Sloane R, Green JB, Zhou J, Pieper CF, Pearson MP, Peterson ED, Cohen HJ, Morey MC. Povsic TJ, et al. Among authors: green jb. J Diabetes Complications. 2013 Nov-Dec;27(6):633-6. doi: 10.1016/j.jdiacomp.2013.08.004. Epub 2013 Sep 19. J Diabetes Complications. 2013. PMID: 24055327 Free PMC article.

10

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

Green JB, Bethel MA, Paul SK, Ring A, Kaufman KD, Shapiro DR, Califf RM, Holman RR. Green JB, et al. Am Heart J. 2013 Dec;166(6):983-989.e7. doi: 10.1016/j.ahj.2013.09.003. Epub 2013 Oct 23. Am Heart J. 2013. PMID: 24268212 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters